Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$132.96
+1.8%
$133.61
$111.83
$141.16
$7.31B0.751.70 million shs1.80 million shs
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
$258.02
+0.3%
$262.89
$222.27
$271.53
$17.32B0.61188,329 shs86,504 shs
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
$89.98
+1.9%
$92.07
$63.80
$103.52
$6.86B1.1111.70 million shs11.24 million shs
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$140.83
+0.2%
$143.57
$122.59
$148.27
$38.11B0.558.65 million shs8.54 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
0.00%+5.12%+1.01%-1.22%+1.74%
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
-0.01%+1.06%-0.83%-0.57%+4.94%
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
0.00%+7.77%+0.55%+2.28%+8.14%
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
+0.01%+0.62%-0.79%-0.82%+5.52%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
N/AN/AN/AN/AN/AN/AN/AN/A
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
0.00
N/A$157.9018.75% Upside
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
0.00
N/A$288.2511.72% Upside
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
0.00
N/A$117.4830.56% Upside
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
0.00
N/A$156.9011.41% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/AN/AN/AN/AN/A
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
N/AN/AN/AN/AN/AN/A
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
N/AN/AN/AN/AN/AN/A
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
N/AN/A23.22N/AN/AN/AN/AN/A
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
N/AN/A11.47N/AN/AN/AN/AN/A
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/AN/A23.82N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$0.410.31%N/AN/AN/A
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
$3.301.28%N/AN/AN/A
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
N/AN/AN/AN/AN/A
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
$1.991.41%N/AN/AN/A

Latest XLV, VHT, IBB, and XBI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2024
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
Quarterly$0.12603/21/20243/22/20243/27/2024
(Data available from 1/1/2013 forward)

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
N/A54.95 millionN/AOptionable
Vanguard Health Care ETF stock logo
VHT
Vanguard Health Care ETF
N/A67.14 millionN/ANot Optionable
SPDR S&P Biotech ETF stock logo
XBI
SPDR S&P Biotech ETF
N/A76.22 millionN/ANot Optionable
Health Care Select Sector SPDR Fund stock logo
XLV
Health Care Select Sector SPDR Fund
N/A270.62 millionN/ANot Optionable

XLV, VHT, IBB, and XBI Headlines

SourceHeadline
16 out of 24 health care companies beat topline numbers this week- Earnings scorecard16 out of 24 health care companies beat topline numbers this week- Earnings scorecard
msn.com - May 4 at 6:09 PM
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts OutlookETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
zacks.com - May 1 at 12:01 PM
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? (XLV)CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? (XLV)
marketbeat.com - April 30 at 9:25 AM
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
zacks.com - April 24 at 1:06 PM
Beyond "Big Six:" Why Choose Non-Cyclical Sector ETFs?Beyond "Big Six:" Why Choose Non-Cyclical Sector ETFs?
zacks.com - April 24 at 9:01 AM
Capturing Consumer Spending on Health Care with XLVCapturing Consumer Spending on Health Care with XLV
finance.yahoo.com - April 22 at 9:36 AM
3 Biotech Stocks Set to Double by 20283 Biotech Stocks Set to Double by 2028
investorplace.com - April 20 at 6:15 AM
UnitedHealth Rises on Q1 Earnings Beat: ETFs to GainUnitedHealth Rises on Q1 Earnings Beat: ETFs to Gain
msn.com - April 17 at 1:54 PM
UnitedHealth Rises on Q1 Earnings Beat: ETFs to GainUnitedHealth Rises on Q1 Earnings Beat: ETFs to Gain
zacks.com - April 17 at 12:11 PM
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in FocusJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
zacks.com - April 17 at 11:00 AM
Citi’s Results Say This About The Stock Market (XLV)Citi’s Results Say This About The Stock Market (XLV)
marketbeat.com - April 15 at 7:14 AM
4 Sector ETFs & Stocks to Benefit From Hot Inflation4 Sector ETFs & Stocks to Benefit From Hot Inflation
zacks.com - April 11 at 3:11 PM
3 High Dividend Stocks to Replace Lower Savings Yields Ahead (XLV)3 High Dividend Stocks to Replace Lower Savings Yields Ahead (XLV)
marketbeat.com - April 11 at 11:09 AM
3 Sector ETFs & Stocks to Bet on March Jobs Data3 Sector ETFs & Stocks to Bet on March Jobs Data
zacks.com - April 9 at 9:01 AM
EXCLUSIVE: Pharmas Cloud Revolution — A $60B Market By 2030 With 1 Stock To WatchEXCLUSIVE: Pharma's Cloud Revolution — A $60B Market By 2030 With 1 Stock To Watch
markets.businessinsider.com - March 28 at 10:10 AM
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
zacks.com - March 25 at 7:20 AM
Nvidias AI Tech Part of Novo Nordisks New Supercomputer  (XLV)Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer (XLV)
marketbeat.com - March 24 at 1:53 PM
Health Care Select Sector SPDR ETFHealth Care Select Sector SPDR ETF
wsj.com - March 22 at 5:09 PM
Health Care Select Sector SPDR Fund (XLV)Health Care Select Sector SPDR Fund (XLV)
finance.yahoo.com - March 15 at 4:00 PM
Consider an Equal Weight Strategy Amid Renewed VolatilityConsider an Equal Weight Strategy Amid Renewed Volatility
etftrends.com - March 15 at 12:16 PM
4 Best Sector ETFs to Play Now4 Best Sector ETFs to Play Now
zacks.com - March 14 at 3:01 PM
Health Care Up as Sector Gathers Upward Momentum -- Health Care RoundupHealth Care Up as Sector Gathers Upward Momentum -- Health Care Roundup
marketwatch.com - March 9 at 12:54 AM
bluebird bio Stock Signals Potential to be a Multi-bagger  (XLV)bluebird bio Stock Signals Potential to be a Multi-bagger (XLV)
marketbeat.com - February 29 at 9:57 AM
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One Youd ExpectBeyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
markets.businessinsider.com - February 27 at 1:26 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iShares Biotechnology ETF logo

iShares Biotechnology ETF

NASDAQ:IBB
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.
Vanguard Health Care ETF logo

Vanguard Health Care ETF

NYSEARCA:VHT
Vanguard Health Care ETF seeks to track the investment performance of the MSCI US Investable Market Health Care 25/50 Index, a benchmark of large-, mid-, and small-cap United States stocks in the health care sector, as classified under the Global Industry Classification Standard (GICS). This GICS sector is made up of two main industry groups. The first group includes companies that manufacture health care equipment and supplies or provide health care related services (such as distributors of health care products, providers of basic health care services, and owners and operators of health care facilities and organizations). The second group includes companies primarily involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. The Vanguard Group, Inc., through its Quantitative Equity Group, serves as the investment advisor of the Fund.
SPDR S&P Biotech ETF logo

SPDR S&P Biotech ETF

NYSEARCA:XBI
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Health Care Select Sector SPDR Fund logo

Health Care Select Sector SPDR Fund

NYSEARCA:XLV
Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager.